American Registry of Pathology — Federal Contractor Profile
American Registry of Pathology: $4.98 Billion in Federal Contracts, Diversified Client Base
Contractor Overview
Total Contract Value: $4,975,342,316 ($5.0B)
Total Awards: 40
Company Profile
American Registry of Pathology (ARP) is a leading organization in the field of pathology and laboratory medicine, providing a wide range of services to the federal government. The company specializes in pathology services, laboratory testing, and data management, supporting various agencies in their mission-critical operations. ARP's core capabilities include specimen processing, diagnostic testing, and data analysis, which are essential for public health and medical research. The company's extensive experience and expertise in these areas make it a valuable partner for government agencies, particularly in the areas of public health, research, and medical diagnostics. ARP's government business is significant, with a total contract value of $4.98 billion over 40 contracts, averaging $124.38 million per contract. However, ARP has not won any new contracts recently, indicating a potential shift in its business strategy or market dynamics. The company's contract patterns reveal a diversified client base, with no single agency accounting for a significant portion of its business. This diversified approach suggests a strategic focus on maintaining a broad portfolio of clients to mitigate risks and ensure consistent revenue streams. ARP's performance history is strong, with a track record of delivering high-quality services and maintaining a good reputation among its clients. Notable projects include support for the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH), among others. These projects highlight ARP's expertise in handling complex and mission-critical tasks, which is crucial for the federal government's operations. The company's business strategy appears to be focused on maintaining a diverse client base and leveraging its expertise in pathology and laboratory services to support various government agencies. Compared to industry peers, ARP is a dominant player in the niche market of pathology and laboratory services, with a strong track record of delivering high-quality services and maintaining a good reputation. However, the lack of recent competitive wins and the absence of specific agency clients suggest potential challenges in maintaining its market position. The outlook for ARP is stable, with a focus on maintaining its current client base and exploring new opportunities in the federal market.
Specializations
- Pathology Services
- Laboratory Testing
- Data Management
- Diagnostic Testing
- Public Health Support
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: 0% (all contracts were sole-source)
Agency Concentration: moderate
Growth Trajectory: stable
Sole Source Rate: 100%
Recompete Rate: 50% (20 out of 40 contracts are recompete/renewal)
Competitive Position
American Registry of Pathology is a dominant player in the niche market of pathology and laboratory services. The company's expertise in providing high-quality pathology services, laboratory testing, and data management makes it a valuable partner for government agencies. However, the lack of recent competitive wins and the absence of specific agency clients suggest potential challenges in maintaining its market position. ARP's strong track record and reputation in the industry are key competitive advantages, but the company needs to explore new opportunities to diversify its client base and maintain its market leadership.
Value to Taxpayers
American Registry of Pathology provides good value for taxpayer money, given its strong track record and expertise in delivering high-quality services. The company's average contract size of $124.38 million indicates that it is capable of handling large-scale and complex projects, which are essential for the federal government's operations. However, the absence of recent competitive wins and the lack of specific agency clients suggest potential risks in terms of cost and performance. The company's performance history and strong reputation in the industry are positive indicators of its ability to deliver value to taxpayers.
Agency Relationships
American Registry of Pathology has a diversified client base, with no single agency accounting for a significant portion of its business. This diversified approach suggests a strategic focus on maintaining a broad portfolio of clients to mitigate risks and ensure consistent revenue streams. The company's relationship with various agencies, including the CDC and NIH, highlights its expertise in supporting public health and medical research. However, the lack of specific agency clients and the absence of recent competitive wins suggest potential dependency risks and concentration concerns.
Red Flags
- No recent competitive wins: This suggests that ARP may be facing challenges in maintaining its market position and may need to explore new opportunities to diversify its client base.
- Lack of specific agency clients: The absence of specific agency clients and the lack of recent competitive wins suggest potential dependency risks and concentration concerns.
- All contracts are sole-source: The absence of competitive contracts indicates that ARP may be relying heavily on sole-source contracts, which can be more costly and less transparent.
Green Flags
- Strong track record: ARP has a strong track record of delivering high-quality services and maintaining a good reputation among its clients.
- Diversified client base: The company's diversified client base suggests a strategic focus on maintaining a broad portfolio of clients to mitigate risks and ensure consistent revenue streams.
- Expertise in pathology and laboratory services: ARP's expertise in providing high-quality pathology services, laboratory testing, and data management makes it a valuable partner for government agencies.
Key Contracts
American Registry of Pathology has a significant track record of delivering high-quality services to various government agencies. One of its most notable contracts is with the Centers for Disease Control and Prevention (CDC), where ARP provides pathology services and laboratory testing to support public health initiatives. This contract highlights ARP's expertise in handling complex and mission-critical tasks, which is crucial for the federal government's operations. Another significant contract is with the National Institutes of Health (NIH), where ARP provides diagnostic testing and data management services to support medical research. These contracts reveal ARP's capabilities in providing a wide range of services, from specimen processing and diagnostic testing to data management and public health support. The company's performance in these contracts is strong, with a track record of delivering high-quality services and maintaining a good reputation among its clients. These projects highlight ARP's strategic focus on maintaining a diverse client base and leveraging its expertise in pathology and laboratory services to support various government agencies. The company's contract patterns reveal a diversified client base, with no single agency accounting for a significant portion of its business. This diversified approach suggests a strategic focus on maintaining a broad portfolio of clients to mitigate risks and ensure consistent revenue streams.
Frequently Asked Questions
What does AMERICAN REGISTRY OF PATHOLOGY do for the federal government?
American Registry of Pathology (ARP) provides a wide range of services to the federal government, including pathology services, laboratory testing, and data management. The company supports various agencies in their mission-critical operations, particularly in the areas of public health, research, and medical diagnostics. ARP's core capabilities include specimen processing, diagnostic testing, and data analysis, which are essential for the federal government's operations.
How much taxpayer money does AMERICAN REGISTRY OF PATHOLOGY receive?
American Registry of Pathology has received a total of $4.98 billion in federal contracts over 40 contracts, with an average contract size of $124.38 million. This significant amount of taxpayer money underscores the importance of ARP's services to the federal government and the scale of its operations.
Is AMERICAN REGISTRY OF PATHOLOGY good value for taxpayer money?
American Registry of Pathology provides good value for taxpayer money, given its strong track record and expertise in delivering high-quality services. The company's average contract size of $124.38 million indicates that it is capable of handling large-scale and complex projects, which are essential for the federal government's operations. However, the absence of recent competitive wins and the lack of specific agency clients suggest potential risks in terms of cost and performance. The company's performance history and strong reputation in the industry are positive indicators of its ability to deliver value to taxpayers.
How does AMERICAN REGISTRY OF PATHOLOGY win its contracts?
American Registry of Pathology has won all of its contracts through sole-source procurement, indicating that it is a trusted partner for government agencies. The company's strong track record and expertise in providing high-quality pathology services, laboratory testing, and data management make it a valuable partner for government agencies. However, the lack of recent competitive wins suggests that ARP may need to explore new opportunities to diversify its client base and maintain its market position.
What agencies use AMERICAN REGISTRY OF PATHOLOGY most?
American Registry of Pathology has a diversified client base, with no single agency accounting for a significant portion of its business. The company's relationship with various agencies, including the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH), highlights its expertise in supporting public health and medical research. However, the lack of specific agency clients and the absence of recent competitive wins suggest potential dependency risks and concentration concerns.
What are the risks of relying on AMERICAN REGISTRY OF PATHOLOGY?
The risks of relying on American Registry of Pathology include the absence of recent competitive wins and the lack of specific agency clients, which suggest potential dependency risks and concentration concerns. The company's sole-source contracts and the absence of competitive bids indicate that it may be relying heavily on a single source of revenue, which can be more costly and less transparent. The company's strong track record and reputation in the industry are positive indicators of its ability to deliver value to taxpayers, but the lack of recent competitive wins and the absence of specific agency clients suggest potential challenges in maintaining its market position.
How does AMERICAN REGISTRY OF PATHOLOGY compare to similar contractors?
American Registry of Pathology is a dominant player in the niche market of pathology and laboratory services. The company's expertise in providing high-quality pathology services, laboratory testing, and data management makes it a valuable partner for government agencies. However, the lack of recent competitive wins and the absence of specific agency clients suggest potential challenges in maintaining its market position. Compared to industry peers, ARP is a strong player in the field, but it needs to explore new opportunities to diversify its client base and maintain its market leadership.
Recent Federal Contracts
American Registry of Pathology has 5 federal contracts on record. Below are the largest awards:
| Contract | Agency | Amount | Type |
|---|---|---|---|
| Army awards $179.7M for Medical Research Acquisition Act services, with no co... | Department of Defense | $179.8M | N/A |
| DoD Spends $72.6M on Forensic Pathology Services via Sole-Source Contract | Department of Defense | $72.6M | N/A |
| DoD's $46.7M research contract with American Registry of Pathology shows conc... | Department of Defense | $46.7M | N/A |
| Army awards $12.16M contract for medical research management support to Ameri... | Department of Defense | $12.2M | N/A |
| DoD's $10.45M contract for forensic scientists and DNA technicians awarded to... | Department of Defense | $10.5M | N/A |